Evidence map›Paper›PMID 34528183›Full record

ReviewCurrent HIV/AIDS reports2021

Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies.

Rachel Logan, Dominika Seidman

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rachel Logan, Tampa, USA.ORCID 0000-0001-7686-5754
Dominika SeidmanZuckerberg San Francisco General Hospital, 1001 Potrero Ave Ward 6D, San Francisco, CA, 94110, USA. Dominika.seidman@ucsf.edu.

Funding

WOMEN'S REPRODUCTIVE HEALTH RESEARCH CENTERK12HD001262 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Andrea Vashti Jackson · 1998 to 2026
$9.3M
Offering Women with PrEP with Education, shared decision-making and trauma-informed care: the OPENS trialR01MD013565 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEHLENDORF, CHRISTINE E · 2018 to 2022
$2.9M
NICHD NIH HHS K12 HD001262NIH HHS 5K12HD001262-18NIMHD NIH HHS R01 MD013565
6 · The paper itself

Abstract

purpose of reviewThis review describes lessons learned from longer acting contraception and employs a reproductive justice lens to inform expansion of emerging HIV prevention technologies. RECENT

findingsReproductive justice is a framework that advocates for the promotion of universal sexual and reproductive freedoms, particularly among historically marginalized communities. This framework takes a holistic view of individuals and sees the interconnections between sexual health, reproductive health, and overall health. Employing a sexual and reproductive justice perspective is essential to understanding and helping to mitigate the role intersecting structural, sexual, and reproductive oppressions, including those demonstrated through promotion of longer acting contraception, and can critically inform rollout of future prevention technologies, such as longer acting HIV pre-exposure prophylaxis. This review highlights the need for researchers, clinicians, and policymakers to apply lessons learned from contraception and specifically focuses on principles of reproductive justice to offer expanding HIV prevention options.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisContraceptionHumansSexual BehaviorFamily planningHealth equityLARCPrEPReproductive justiceSexual health

Identifiers

PMID34528183
PMCPMC8442650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.